ozempic glp 1 New GLP-1; Semaglutide (Ozempic) What You Should Know Before

3135,41,42 They have also demonstrated efficacy in treating non-alcoholic fatty liver disease, a condition linked to chronic inflammation and metabolic dysfunction that can adversely affect healthspan

Check TSH levels 6-8 weeks after starting GLP-1 therapy and after each significant weight milestone

Licensed GLP-1 Medicines in the UK *Wegovy can also reduce the risk of heart attacks and strokes in overweight or obese individuals

The evidence suggests this may be a class effect related to GLP-1 receptor activation rather than specific to semaglutide alone

For comparison, nausea has been reported at approximately 44% in the Wegovy semaglutide trials and 28% in the Zepbound tirzepatide trials

We are not affiliated with Novo Nordisk or Eli Lilly and we do not supply their products, and their trademarks are their own